Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer

American Journal of Surgery

Volumn 199, Issue 4, 2010, Pages 477-484

  Keune, Jason D ^a   Jeffe, Donna B ^a,b   Schootman, Mario ^a,b   Hoffman, Abigail ^d   Gillanders, William E ^a,b   Aft, Rebecca L ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Breast carcinoma; Breast ultrasound mammography; Neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTIPLE CYCLE TREATMENT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; ULTRASONOGRAPHY, MAMMARY;

EID: 77949907290     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.03.012     Document Type: Article

References (53)

1. Kaufmann M., von Minckwitz G., Smith R., et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 21 (2003) 2600-2608
2. Wolff A.C., and Davidson N.E. Primary systemic therapy in operable breast cancer. J Clin Oncol 18 (2000) 1558-1569
3. Makris A., Powles T.J., Ashley S.E., et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 9 (1998) 1179-1184
4. Rouzier R., Mathieu M.C., Sideris L., et al. Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors. Cancer 101 (2004) 918-925
5. van der Hage J.A., van de Velde C.J., Julien J.P., et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19 (2001) 4224-4237
6. Wolmark N., Wang J., Mamounas E., et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 30 (2001) 96-102
7. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16 (1998) 2672-2685
8. Kuerer H.M., Newman L.A., Smith T.L., et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17 (1999) 460-469
9. Cance W.G., Carey L.A., Calvo B.F., et al. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 236 (2002) 295-3
10. Carey L.A., Metzger R., Dees E.C., et al. American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome. J Natl Cancer Inst 97 (2005) 1137-1142
11. Mauri D., Pavlidis N., and Ioannidis J.P. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 97 (2005) 188-194
12. Reitsamer R., Peintinger F., Prokop E., and Hitzl W. Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer. Anticancer Drugs 16 (2005) 867-870
13. Denis F., Desbiez-Bourcier A.V., Chapiron C., et al. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol 30 (2004) 1069-1076
14. Fiorentino C., Berruti A., Bottini A., et al. Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. Breast Cancer Res Treat 69 (2001) 143-151
15. Forouhi P., Walsh J.S., Anderson T.J., and Chetty U. Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment. Br J Surg 81 (1994) 223-225
16. Herrada J., Iyer R., Atkinson E., et al. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 9 (1997) 1565-1569
17. Londero V., Bazzocchi M., Del Frate C., et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14 (2004) 1371-1379
18. Moskovic E., Mansi J., King D., et al. Mammography in the assessment of response to medical treatment of large primary breast cancer. Clin Radiol 47 (1993) 339-344
19. Rosen E.L., Blackwell K.L., Baker J.A., et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181 (2003) 1275-1282
20. Vinnicombe S.J., MacVicar A.D., Guy R.L., et al. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 198 (1996) 333-340
21. Yeh E., Slanetz P., Kopans D.B., et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184 (2005) 868-877
22. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233 (2004) 830-849
23. Bosch A.M., Kessels A.G., Beets G.L., et al. Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours. Eur J Radiol 48 (2003) 285-292
24. Hieken T.J., Harrison J., Herreros J., and Velasco J.M. Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg 182 (2001) 351-354
25. Kald B.A., Boiesen P., Ronnow K., et al. Preoperative assessment of small tumours in women with breast cancer. Scand J Surg 94 (2005) 15-20
26. Madjar H., Ladner H.A., Sauerbrei W., et al. Preoperative staging of breast cancer by palpation, mammography and high-resolution ultrasound. Ultrasound Obstet Gynecol 3 (1993) 185-190
27. Yang W.T., Lam W.W., Cheung H., et al. Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. J Ultrasound Med 16 (1997) 791-797
28. Sinn H.P., Schmid H., Junkermann H., et al. Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy. Geburtshilfe Frauenheilkd 54 (1994) 552-558
29. El-Didi M.H., Moneer M.M., Khaled H.M., and Makarem S. Pathological assessment of the response of locally advanced breast cancer to neoadjuvant chemotherapy and its implications for surgical management. Surg Today 30 (2000) 249-254
30. Huber S., Medl M., Vesely M., et al. Ultrasonographic tissue characterization in monitoring tumor response to neoadjuvant chemotherapy in locally advanced breast cancer (work in progress). J Ultrasound Med 19 (2000) 677-686
31. Byrt T., Bishop J., and Carlin J.B. Bias, prevalence and kappa. J Clin Epidemiol 46 (1993) 423-429
32. Hoehler F.K. Bias and prevalence effects on kappa viewed in terms of sensitivity and specificity. J Clin Epidemiol 53 (2000) 499-503
33. Landis J.R., and Koch G.G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33 (1977) 363-374
34. Davidson N.E., and Morrow M. Sometimes a great notion-an assessment of neoadjuvant systemic therapy for breast cancer. J Natl Cancer Inst 97 (2005) 159-161
35. Buchholz T.A., Tucker S.L., Masullo L., et al. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 20 (2002) 17-23
36. Chen A.M., Meric-Bernstam F., Hunt K.K., et al. Breast conservation after neoadjuvant chemotherapy. Cancer 103 (2005) 689-695
37. Pain J.A., Ebbs S.R., Hern R.P., et al. Assessment of breast cancer size: a comparison of methods. Eur J Surg Oncol 18 (1992) 44-48
38. Golshan M., Fung B.B., Wiley E., et al. Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast 13 (2004) 265-271
39. Warren R., Bobrow L., Earl H., et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?. Br J Cancer 90 (2004) 1349-1360
40. Loehberg C.R., Lux M.P., Ackermann S., et al. Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used?. Anticancer Res 25 (2005) 2519-2525
41. Fornage B., Toubas O., and Morel M. Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer 60 (1987) 765-771
42. Helvie M.A., Joynt L.K., Cody R.L., et al. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 198 (1996) 327-332
43. Moneer M., El-Didi M., and Khaled H. Breast conservative surgery: is it appropriate for locally advanced breast cancer following downstaging by neoadjuvant chemotherapy?. A pathological assessment. Breast 8 (1999) 315-319
44. Sauven P. The surgical management of patients following neoadjuvant chemotherapy for locally advanced breast cancer. Eur J Cancer 38 (2002) 2371-2374
45. Kuerer H.M., Singletary S.E., Buzdar A.U., et al. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg 182 (2001) 601-608
46. Cocconi G., Di Blasio B., Alberti G., et al. Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 4 (1984) 309-313
47. Huber S., Wagner M., Zuna I., et al. Locally advanced breast carcinoma: evaluation of mammography in the prediction of residual disease after induction chemotherapy. Anticancer Res 20 (2000) 553-558
48. Seymour M.T., Moskovic E.C., Walsh G., et al. Ultrasound assessment of residual abnormalities following primary chemotherapy for breast cancer. Br J Cancer 76 (1997) 371-376
49. Tardivon A.A., Ollivier L., El Khoury C., and Thibault F. Monitoring therapeutic efficacy in breast carcinomas. Eur Radiol 16 (2006) 2549-2558
50. Esserman L., Hylton N., Yassa L., et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17 (1999) 110-119
51. Akazawa K., Tamaki Y., Taguchi T., et al. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy. Breast J 12 (2006) 130-137
52. von Minckwitz G., Costa S.D., Eiermann W., et al. Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel. J Clin Oncol 17 (1999) 1999-2005
53. Peintinger F., Kuerer H.M., Anderson K., et al. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol 13 (2006) 1443-1449